Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2006; 12(30): 4773-4783
Published online Aug 14, 2006. doi: 10.3748/wjg.v12.i30.4773
Published online Aug 14, 2006. doi: 10.3748/wjg.v12.i30.4773
Figure 1 400-MHz 1H HR-MAS NMR spectra of a human liver biopsy sample (rotation rate 4 kHz).
A: Standard 1D spectrum; B: Spin-echo (CPMG) spectrum; C: JRES f2 projection. L1: lipid CH3; L2: lipid (CH2)n; L3: lipid CH2CH2CO; L4: lipid CH2-CH=CH; L5: lipid CH2CO; L6: lipid CH=CH-CH2-CH=CH; L7: lipid CH=CH; Cho: choline; PC: phosphocholine; GPC: glycerophosphocholine; TMAO: trimethylamine-N-oxide; Bet: betaine; Glc: glucose; Val: valine; Leu, leucine; Ala: alanine; Gln: glutamine; Gly: glycine; Tyr: tyrosine; Urd: uridine; Ado: adenosine. Reprinted with permission from Duarte et al Anal Chem 2005; 77: 5570-5578. Copyright (2005) American Chemical Society.
- Citation: Cox IJ, Sharif A, Cobbold JF, Thomas HC, Taylor-Robinson SD. Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease. World J Gastroenterol 2006; 12(30): 4773-4783
- URL: https://www.wjgnet.com/1007-9327/full/v12/i30/4773.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i30.4773